Preclinical investigations in postmenopausal osteoporosis, breast cancer, and other inflammatory conditions

Document Type

News Article


Established the preclinical screening models of osteoporosis and related postmenopausal inflammatory conditions in animals. Similarly established the models for breast cancer to screen the novel pharmaceutical formulations such as iontophoresis, nanoformulation etc. The phytochemicals such as resveratrol, fenugreek and other plant extracts have been evaluated in these models and the results were published. Further there was great interest in in silico drug screening to repurpose the existing drug to COVID-19 and Lung cancer and pulmonary fibrosis. The US-FDA approved drugs have been screened and possible drugs for COVID-19 were shortlisted using in silico tools from Schrodinger’s Suit. Currently interested in systems and network pharmacology for drug discovery and development.

  1. https://www.sciencedirect.com/science/article/pii/S0939641121001892
  2. https://onlinelibrary.wiley.com/doi/10.1111/jfbc.13690
  3. https://www.sciencedirect.com/science/article/abs/pii/S2772950822003624
  4. https://f1000research.com/articles/11-155

Other Web Profile Links

Ready to guide PhD in the following areas (for both on campus and off-campus)

  1. In silico Pharmacology to screen drugs for lung cancer and lung fibrosis
  2. Systems and network pharmacology for drug discovery from natural products
  3. Free radical biology and medicine, especially in diabetes and related metabolic complications
  4. Preclinical pulmonary pharmacology to screen the drugs in chronic lung diseases
  5. Bibliometric and Scientometric studies in the field of higher education, research and strategic policies

PDF related info: https://manipal.edu/mu/academics/phd.html

We look forward for collaborating with researchers across the globe with common interest. Interested collaborators may contact at yogendra.nayak@manipal.edu

Publication Date

Winter 11-1-2022